In a cluster-randomised trial of 8273 high-transfusion-risk patients having major noncardiac surgery in 10 hospitals, a tranexamic acid policy cut red-cell transfusion vs placebo (7.4% vs 9.8%; RR 0.73); 90-day VTE was noninferior (2.1% vs 2.1%).
RCTn = 8,273
Houston et al. Hospital Policy of Tranexamic Acid to Reduce Transfusion in Major Noncardiac Surgery